Glucagon-Like Peptide-1 Agonist (GLP-1) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: GLP-1RA

Top Sponsors

Ohio State University1

Indications

Diabetes (DM)1
Obesity & Overweight1
Weight Loss1
Diabetes1

Columbus, Ohio1 trial

Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

The Ohio State University

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.